4.4 Review

Syn, anti, and finally both conformations of cyclic AMP are involved in the CRP-dependent transcription initiation mechanism in E. coli lac operon

期刊

CELL BIOCHEMISTRY AND FUNCTION
卷 26, 期 4, 页码 399-405

出版社

JOHN WILEY & SONS LTD
DOI: 10.1002/cbf.1462

关键词

transcription activation; cAMP conformation; CRP allostery

向作者/读者索取更多资源

The cyclic AMP receptor protein (CRP) of Escherichia coli regulates the activity of more than 150 genes. Allosteric changes in CRP structure accompanied by cAMP binding, initiate transcription through protein binding to specific DNA sequences. Initially, researchers proposed a two-site cAMP-binding model for CRP-dependent transcription activation since biophysical methods showed two transitions during titration experiments. Three conformational states were considered; apo-CRP, CRP:(cAMP)(1) and CRP:(cAMP)(2), and CRP:(cAMP)(1) was proposed as the active form in this initial model. X-ray data indicated an anti conformation and in contrast NMR experiments suggested a syn conformation for bound cAMPs. For years this paradigm about ligand conformation has been ambiguous. When CRP was crystallized with four bound cAMP in the last decade, two cAMPs were assigned to syn and the other two to anti conformations. Again three conformational states were suggested; apo-CRP, CRP:(cAMP)(2), and CRP:(cAMP)(4). This new structure changed the view of CRP allosteric activation from a two-site model to a four-site model in the literature and the new model has been supported by biochemical and genetic data so far. According to the accepted model, binding of the first two cAMP molecules displays positive cooperativity, however, binding of the last two cAMP molecules shows negative cooperativity. This resolved the conflict between dynamic and static experimental observations. However, this new model cannot explain the initiation mechanism as previously proposed because functionally active CRP has only one cAMP equivalent. Gene regulation and transcription factors are involved in regulating both prokaryotic and eukaryotic metabolism. Although gene regulation and expression are much more complex in eukaryotes, CRP-mediated transcription initiation is a model of general interest to life sciences and medicine. Therefore, the aim of this review is to Summarize recent works and developments on the cAMP-dependent CRP activation mechanism in E. coli. Copyright (C) 2008 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Cell Biology

Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators

Ayman M. Mahmoud, M. Yvonne Alexander, Yusuf Tutar, Fiona L. Wilkinson, Alessandro Venditti

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Article Chemistry, Inorganic & Nuclear

Anticancer activities of manganese-based photoactivatable CO-releasing complexes (PhotoCORMs) with benzimidazole derivative ligands

Elvan Ustun, Aykut Ozgur, Kubra A. Coskun, Serpil Demir Dusunceli, Ismail Ozdemir, Yusuf Tutar

TRANSITION METAL CHEMISTRY (2017)

Editorial Material Respiratory System

Non-coding RNAs in lung cancer

Esen Tutar, Yusuf Tutar

JOURNAL OF THORACIC DISEASE (2019)

Review Biochemistry & Molecular Biology

The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance

Magdalena Rudzinska, Alessandro Parodi, Surinder M. Soond, Andrey Z. Vinarov, Dmitry O. Korolev, Andrey O. Morozov, Cenk Daglioglu, Yusuf Tutar, Andrey A. Zamyatnin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Perturbation of HSP Network in MCF-7 Breast Cancer Cell Line Triggers Inducible HSP70 Expression and Leads to Tumor Suppression

Mustafa Ergul, Fugen Aktan, Mehmet T. Yildiz, Yusuf Tutar

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)

Article Oncology

Designing Specific HSP70 Substrate Binding Domain Inhibitor for Perturbing Protein Folding Pathways to Inhibit Cancer Mechanism

Kubra A. Coskun, Irfan Koca, Mehmet Gumus, Yusuf Tutar

Summary: The research aimed to design a novel HSP70 inhibitor, KBR1307, which can bind to HSP70 in the presence and absence of nucleotides, effectively inhibit HSP70 activity, and display a lower IC50 value in the MCF-7 cell line compared to PES. This suggests that KBR1307 may be a more promising template for novel anticancer drug development.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Article Andrology

ATPase inhibition by omeprazole reveals role of heat shock proteins on testicular torsion

Cengiz Guney, Kubra Acikalin Coskun, Yusuf Tutar

Summary: Testicular torsion leads to tissue damage, with HSPs playing an important role in the process. Omeprazole was found to effectively alleviate lipid peroxidation and DNA damage levels, promoting testicular torsion recovery.

ANDROLOGIA (2021)

Editorial Material Biochemistry & Molecular Biology

Short Commentary on Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis, and Therapy

Yusuf Tutar

CURRENT MEDICINAL CHEMISTRY (2020)

Article Oncology

Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma

Altan Kara, Aykut Ozgur, Saban Tekin, Yusuf Tutar

Summary: This study investigated the relationship between differentially expressed genes affecting patient survival and the mechanism of drug resistance in non-small cell lung adenocarcinoma. The results showed that several signaling pathways were associated with drug resistance in NSCLC cells.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Article Biochemical Research Methods

Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design

Mustafa Ergul, Fugen Aktan, Yusuf Tutar

Summary: This study identified three loss-of-function mutants of Hsp70, which may affect the inhibition activity of drugs. Designing inhibitors by considering these critical residues may improve drug design and increase drug efficiency.

CURRENT PROTEOMICS (2022)

Review Oncology

Performance of capecitabine in novel combination therapies in colorectal cancer

Fahima Danesh Pouya, Yousef Rasmi, Irem Yalim Camci, Yusuf Tutar, Mohadeseh Nemati

Summary: Colorectal cancer is a highly prevalent cancer worldwide with no definitive cure. Targeted therapies and the effectiveness of chemotherapy drugs help improve patient survival rates. Capecitabine is commonly used in standard chemotherapy regimens for colorectal cancer, playing a significant role in combination therapies.

JOURNAL OF CHEMOTHERAPY (2021)

Article Chemistry, Multidisciplinary

Pyrazolyl-Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer

Irfan Koca, Volkan Kamaci, Ceylan Ozsoy, Yusuf Sert, Ibrahim Kani, Lutfi Tutar, Yusuf Tutar

Summary: Heat Shock Proteins (Hsps) play a major role in cancer onset. Cancer cells have a higher metabolic rate compared to normal cells, resulting in faster folding of substrate proteins. Hsps help cells survive and inhibit apoptosis, folding substrate proteins, especially signaling proteins. Dual inhibition of Hsp90 and Hsp70 potentially provides anti-cancer effects.

CHEMISTRYSELECT (2022)

Article Biochemistry & Molecular Biology

Triad pyrazole-thiazole-coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis

Mehmet Gumus, Irfan Koca, Yusuf Sert, Ali Disli, Ezgi Nurdan Yenilmez Tunoglu, Lutfi Tutar, Yusuf Tutar

Summary: Intensive studies are being conducted on hepatocellular carcinoma (HCC) due to the lack of effective preventive or curative treatments. Understanding the molecular mechanisms and combining drugs with molecular therapies has become crucial for HCC treatment.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Emergency Medicine

Assessment of plasma and tissue fibronectin EIIIB splice variant expressions measured serially using RT-PCR in a wound model of rabbits

Nese Kurt Ozkaya, Umut Zereyak, Kubra Acikalin Coskun, Yusuf Tutar, Sarper Yilmaz

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY (2020)

Review Biochemistry & Molecular Biology

Long noncoding RNA: An emerging diagnostic and therapeutic target in kidney diseases

Kumaresan Ramanathan, Minale Fekadie, Giri Padmanabhan, Henok Gulilat

Summary: Long noncoding RNAs (lncRNAs) play critical roles in kidney disease development and their dysregulation can lead to various disease processes. Understanding the function and potential application of lncRNAs in kidney disease may provide new diagnostic and therapeutic opportunities. This review provides an overview of lncRNA characteristics, function, and specific studies related to kidney disease treatment.

CELL BIOCHEMISTRY AND FUNCTION (2024)